目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Gonorrhea Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Gonorrhea Therapeutics Market 2018 - 2022 ($ million)
4.2 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 Therapy segment analysis 2018 - 2022
Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel
6.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacies - Market size and forecast 2023-2028
Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacies - Market size and forecast 2023-2028
Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacies - Market size and forecast 2023-2028
Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Therapy
7.1 Market segments
Chart on Therapy - Market share 2023-2028 (%)
Data Table on Therapy - Market share 2023-2028 (%)
7.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
7.3 Monotherapy - Market size and forecast 2023-2028
Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
7.4 Combination therapy - Market size and forecast 2023-2028
Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Therapy
Market opportunity by Therapy ($ million)
Data Table on Market opportunity by Therapy ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Apotex Inc.
Apotex Inc. - Overview
Apotex Inc. - Product / Service
Apotex Inc. - Key news
Apotex Inc. - Key offerings
12.4 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
12.5 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.6 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
12.7 Debiopharm International SA
Debiopharm International SA - Overview
Debiopharm International SA - Product / Service
Debiopharm International SA - Key news
Debiopharm International SA - Key offerings
12.8 Entasis Therapeutics
Entasis Therapeutics - Overview
Entasis Therapeutics - Product / Service
Entasis Therapeutics - Key offerings
12.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.10 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.11 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
12.12 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.13 Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd. - Overview
Mayne Pharma Group Ltd. - Business segments
Mayne Pharma Group Ltd. - Key news
Mayne Pharma Group Ltd. - Key offerings
Mayne Pharma Group Ltd. - Segment focus
12.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.15 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Therapyx Inc.
Therapyx Inc. - Overview
Therapyx Inc. - Product / Service
Therapyx Inc. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Gonorrhea Therapeutics Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits33: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Distribution Channel
Exhibits35: Data Table on Comparison by Distribution Channel
Exhibits36: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Distribution Channel ($ million)
Exhibits49: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits50: Chart on Therapy - Market share 2023-2028 (%)
Exhibits51: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Therapy
Exhibits53: Data Table on Comparison by Therapy
Exhibits54: Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Therapy ($ million)
Exhibits63: Data Table on Market opportunity by Therapy ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ million)
Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: Apotex Inc. - Overview
Exhibits114: Apotex Inc. - Product / Service
Exhibits115: Apotex Inc. - Key news
Exhibits116: Apotex Inc. - Key offerings
Exhibits117: Aurobindo Pharma Ltd. - Overview
Exhibits118: Aurobindo Pharma Ltd. - Product / Service
Exhibits119: Aurobindo Pharma Ltd. - Key offerings
Exhibits120: Bristol Myers Squibb Co. - Overview
Exhibits121: Bristol Myers Squibb Co. - Product / Service
Exhibits122: Bristol Myers Squibb Co. - Key news
Exhibits123: Bristol Myers Squibb Co. - Key offerings
Exhibits124: Cipla Inc. - Overview
Exhibits125: Cipla Inc. - Business segments
Exhibits126: Cipla Inc. - Key news
Exhibits127: Cipla Inc. - Key offerings
Exhibits128: Cipla Inc. - Segment focus
Exhibits129: Debiopharm International SA - Overview
Exhibits130: Debiopharm International SA - Product / Service
Exhibits131: Debiopharm International SA - Key news
Exhibits132: Debiopharm International SA - Key offerings
Exhibits133: Entasis Therapeutics - Overview
Exhibits134: Entasis Therapeutics - Product / Service
Exhibits135: Entasis Therapeutics - Key offerings
Exhibits136: F. Hoffmann La Roche Ltd. - Overview
Exhibits137: F. Hoffmann La Roche Ltd. - Business segments
Exhibits138: F. Hoffmann La Roche Ltd. - Key news
Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits141: GlaxoSmithKline Plc - Overview
Exhibits142: GlaxoSmithKline Plc - Business segments
Exhibits143: GlaxoSmithKline Plc - Key news
Exhibits144: GlaxoSmithKline Plc - Key offerings
Exhibits145: GlaxoSmithKline Plc - Segment focus
Exhibits146: Hikma Pharmaceuticals Plc - Overview
Exhibits147: Hikma Pharmaceuticals Plc - Business segments
Exhibits148: Hikma Pharmaceuticals Plc - Key news
Exhibits149: Hikma Pharmaceuticals Plc - Key offerings
Exhibits150: Hikma Pharmaceuticals Plc - Segment focus
Exhibits151: Lupin Ltd. - Overview
Exhibits152: Lupin Ltd. - Product / Service
Exhibits153: Lupin Ltd. - Key news
Exhibits154: Lupin Ltd. - Key offerings
Exhibits155: Mayne Pharma Group Ltd. - Overview
Exhibits156: Mayne Pharma Group Ltd. - Business segments
Exhibits157: Mayne Pharma Group Ltd. - Key news
Exhibits158: Mayne Pharma Group Ltd. - Key offerings
Exhibits159: Mayne Pharma Group Ltd. - Segment focus
Exhibits160: Pfizer Inc. - Overview
Exhibits161: Pfizer Inc. - Product / Service
Exhibits162: Pfizer Inc. - Key news
Exhibits163: Pfizer Inc. - Key offerings
Exhibits164: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits165: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits166: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits167: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits168: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits169: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits170: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits171: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits172: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits173: Therapyx Inc. - Overview
Exhibits174: Therapyx Inc. - Product / Service
Exhibits175: Therapyx Inc. - Key offerings
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Information sources
Exhibits181: Data validation
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Data synthesis
Exhibits184: 360 degree market analysis
Exhibits185: List of abbreviations